Twi Pharmaceuticals, Inc.
Overview
Twi Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Paramus, United States, founded in 2010, with 201-500 employees.
API / Drug Master Files
Twi Pharmaceuticals, Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- NAPRELAN (NAPROXEN SODIUM) CONTROLLED-RELEASE TABLETS, 375MG, 500MG, 750MGActive2008-08-12
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Twi Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Twi Pharmaceuticals, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.